Product NDC 61314-0454

3 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 61314-0454 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 3 active presentations.
  • Generic family: adalimumab-adaz.
  • Primary dosage form: Injection.
  • Common strength: 80 mg / .8mL.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: Sandoz Inc.
  • Dosage forms shown: Injection.
  • Package quantities: 2 Syringe, 3 Syringe, and 3 Syringe, Glass.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
adalimumab-adaz 80 mg / .8mL Injection 0.8 mL (Hyrimoz)61314-0454-2080 mg / .8mLInjection2 Syringe
adalimumab-adaz 80 mg / .8mL Injection 0.8 mL (Hyrimoz)61314-0454-3680 mg / .8mLInjection3 Syringe
adalimumab-adaz 80 mg / .8mL Injection 0.8 mL (Hyrimoz)61314-0454-6880 mg / .8mLInjection3 Syringe, Glass

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.